MEDIJEL

This brand name is authorized in Cyprus, Hong Kong, Ireland, New Zealand, Singapore, United Kingdom

Active ingredients

The drug MEDIJEL contains a combination of these active pharmaceutical ingredients (APIs):

1 Lidocaine UNII 98PI200987 - LIDOCAINE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. Read about Lidocaine

2 Aminoacridine UNII 78OY3Z0P7Z - AMINACRINE

Read about Aminoacridine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MEDIJEL Oral gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 46135
Country: HK	Department of Health Drug Office	Identifier(s): 07262
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4455
Country: SG	Health Sciences Authority	Identifier(s): 04748P